Facebook Linkedin Mail X Youtube
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe
Search
Facebook Linkedin Mail X Youtube
Cardiovascular News Cardiovascular News
Cardiovascular News Cardiovascular News
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe

Tag: sirolimus

Advanced NanoTherapies secures over US$31 million Series B to deliver dual-drug nanoparticle-coated balloon platform

3rd June 2026
Advanced NanoTherapies (A...

SirPAD: Primary results confirm safety and efficacy of sirolimus-coated balloon in PAD

1st April 2026
In the SirPAD trial, ...

TRANSFORM II study of sirolimus DCB completes patient enrolment

16th June 2025
Enrolment has been comple...

First-in-human results for dual-drug therapy DCB released

26th October 2024
Advanced NanoTherapie...

First patient enrolled in TRANSFORM II study of sirolimus-coated balloon

28th January 2022
The first patient has...

MedAlliance announces first patient enrolment in SELUTION DeNovo study

31st August 2021
MedAlliance today announc...

Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra BioMed enter global strategic partnership

13th June 2019
Orchestra BioMed and Teru...
Cardiovascular News

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube